The Claim

Cyclocreatine inhibits cell growth in C6 rat glioma cells and OC238 human ovarian carcinoma cells without affecting membrane integrity or nucleoside triphosphate levels, indicating that its antiproliferative effects are independent of energy depletion or membrane damage in these in vitro cancer models.

Source: Cyclocreatine transport and cytotoxicity in rat glioma and human ovarian carcinoma cells: 31P-NMR spectroscopy.

What the research says

Roughly balanced

Support and challenge are close. The picture may shift as more studies come in.

Supports
6score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

How it works
1 study reviewed
In plain English

Cyclocreatine slows down the growth of certain cancer cells in a lab dish, but it doesn’t harm their outer layer or energy supply — so it probably works in a different way.

See the scientific wording

Cyclocreatine inhibits cell growth in both C6 rat glioma cells and OC238 human ovarian carcinoma cells, with no observed effect on membrane integrity or nucleoside triphosphate content, suggesting its antiproliferative effects occur independently of energy depletion or membrane damage in these cancer cell lines.

What the research says

1 study

  1. Study: Cyclocreatine transport and cytotoxicity in rat glioma and human ovarian carcinoma cells: 31P-NMR spectroscopy.

    The study shows that cyclocreatine stops cancer cells from growing without harming their energy levels or outer layer, just like the claim says.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.